Every year since 1991, the National Ocean and Atmospheric Administration has offered competitive grants to a small number of ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Leading the nation in cancer diagnoses is Maine, which recorded 650 cancer cases per 100,000 residents in 2021—the highest in the U.S. The most common cancer in Maine is breast cancer, followed ...

Videos are popping up on social media of people burning their Labubu dolls - and there’s a very disturbing reason why. The ...

Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant's portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma's ...

David Spigel, MD, medical oncologist and the chief scientific officer at Sarah Cannon Research Institute in Nashville, Tennessee, discusses the pivotal findings from the AIM-HIGH trial (NCT01817192), ...

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new ...

Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

--Merck is nearing a roughly $10 billion deal to buy lung disease-focused drugmaker Verona Pharma, the Financial Times reports, citing people familiar with the matter. --Merck would pay $107 per ...